Best Weight Loss Treatment UK 2026: Expert Comparison

Best weight loss treatments in the UK for 2026

If you’re struggling to lose weight through diet and exercise alone, weight loss treatments may be an option to consider. In the UK, several prescription medications have gained popularity for their ability to help people shed pounds effectively. This guide looks at the most common weight loss treatments available in 2026—Mounjaro, Wegovy, Ozempic, and Saxenda. We’ll compare their effectiveness, cost, and usage to help you make an informed decision. As always, it’s essential to consult your GP before starting any new medication.

1. Overview of Available weight loss treatments

• Mounjaro (Tirzepatide): A relatively new injectable drug originally developed for type 2 diabetes, Mounjaro has shown impressive weight loss results in clinical trials. It works on dual incretin receptors to regulate appetite and blood sugar.
• Wegovy (Semaglutide 2.4mg): Approved for weight management in the UK, Wegovy is a higher dose version of semaglutide and is designed specifically to help reduce appetite and delay stomach emptying.
• Ozempic (Semaglutide): Primarily a diabetes treatment, Ozempic is often prescribed off-label for weight loss due to its appetite-suppressing benefits, but at lower doses than Wegovy.
• Saxenda (Liraglutide): Licensed for weight management, Saxenda requires daily injections and is a GLP-1 receptor agonist that reduces hunger signals.

2. Comparison Table Overview

3. Best for Weight Loss: Mounjaro

Mounjaro (tirzepatide) currently leads in weight loss effectiveness. Clinical trials show an average weight reduction of about 22.5% of starting body weight over 72 weeks. Initially approved for type 2 diabetes, doctors are increasingly prescribing it off-label for obesity.

The reason for its success lies in its dual action on two gut hormones, GIP and GLP-1, enhancing appetite control and improving metabolism. However, Mounjaro is not yet licensed for weight management by the MHRA in the UK, so NHS prescriptions for weight loss are not available.

Costs are higher versus other injections, and potential side effects include nausea and digestive discomfort. Because it is off-label use, close supervision by a GP or specialist is essential.

4. Best Value: Wegovy

Wegovy, a semaglutide-based injection licensed for weight loss, offers excellent results with an average weight loss of 15-18%. It is the UK’s first injectable weight loss drug specifically approved for this purpose by the MHRA and recommended by some NHS guidelines for patients with BMI over 30 or BMI over 27 with weight-related health problems.

Compared to Mounjaro, Wegovy comes at a lower starting price and a well-established safety profile. It requires a weekly injection, which many patients find convenient. Side effects are similar—mainly mild digestive symptoms—and tend to reduce over time.

Wegovy is increasingly available on the NHS but with strict eligibility criteria. Private prescriptions are an alternative but can be costly. Always talk to your GP about your options.

5. Best for Diabetics: Ozempic

Ozempic (semaglutide) is licensed for type 2 diabetes treatment but increasingly used off-label to assist weight loss. Trials show an average weight